GATA3 and breast cancer: Genomic sequencing in patients from the Young Women's Breast Cancer Study identified higher rates of GATA3 and ARID1A mutations in women < 35 with luminal A cancer compared to those > 45 (43% vs. 12% and 18% vs. 2%, respectively) [25].